Showing results (1261-1270 of 1,686) with videos related to
Sort By:
Pageof 169
American Journal of Obstetrics and Gynecology|October 28, 1998
The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study GroupG M Joffe, J R Esterlitz, R J Levine, et al.Lab on a Chip|January 11, 2014
Standing surface acoustic wave (SSAW)-based microfluidic cytometerYuchao Chen, Ahmad Ahsan Nawaz, Yanhui Zhao, et al.Cureus|October 24, 2025
Detecting Biomarkers of Radiation Pneumonitis in Exhaled Breath During Chemoradiotherapy for Stage III Non-small Cell Lung Cancer: Results of a Prospective Feasibility StudyRyan T Hughes, Kaitlyn E Reno, Beverly J Levine, et al.Structure (London, England : 1993)|December 19, 2023
Accurate modeling of peptide-MHC structures with AlphaFoldVictor Mikhaylov, Chad A Brambley, Grant L J Keller, et al.Proceedings of the National Academy of Sciences of the United States of America|April 18, 2012
Chronic restraint stress attenuates p53 function and promotes tumorigenesisZhaohui Feng, Lianxin Liu, Cen Zhang, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 8, 2026
Encequidar is a multispecies gut-restricted P-glycoprotein inhibitor that delineates between intestinal secretion and biliary elimination in animals and predicts human disposition pathwaysMurali Subramanian, Josh Yu, Gregg Schwarzwalder, et al.Genes & Development|April 27, 2000
Analysis of p53-regulated gene expression patterns using oligonucleotide arraysR Zhao, K Gish, M Murphy, et al.The Journal of Clinical Investigation|August 22, 2002
Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain sheddingXinle Cui, Feras Hawari, Sura Alsaaty, et al.Cancer Research|December 10, 2009
Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and CD44 that affect sarcoma incidence and survivalAlexei Vazquez, Lukasz F Grochola, Elisabeth E Bond, et al.Molecular Cancer Therapeutics|August 7, 2012
A cell-penetrating bispecific antibody for therapeutic regulation of intracellular targetsRichard H Weisbart, Joseph F Gera, Grace Chan, et al.Pageof 169